Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07382258Not ApplicableRecruiting

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease

Role: lead

NCT05896800Not ApplicableRecruiting

A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT06852924Not ApplicableRecruiting

Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)

Role: lead

NCT06852911Not ApplicableRecruiting

FeNO Detection in Asthma Diagnosis: A New Technology Approach

Role: lead

NCT05703191Recruiting

A Real-world Study of Nitric Oxide Generator and Delivery System

Role: lead

NCT05785195Not ApplicableUnknown

A Mechanistic Study of Inhaled Nitric Oxide in COPD

Role: collaborator

All 6 trials loaded